Home      About this journal      Authors      Editors      Readers      Archive      Contact us
Mechanism research of astragaloside Ⅳ on drug-resistant strain of mouse lymphocytic leukemia based on p62-Nrf2 pathway
Hits 673  Download times 464  Received:July 24, 2021  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1672-1519.2021.12.24
Key Words   p62-Nrf2 signaling pathway;astragaloside Ⅳ;chemoresistance
Author NameAffiliationE-mail
WANG Xiaoling College of Integrated Traditional and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
YANG Xiaojuan College of Integrated Traditional and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
ZHENG Qianqian College of Integrated Traditional and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
HOU Mengxue College of Integrated Traditional and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Xu College of Integrated Traditional and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China  
WANG Tao College of Integrated Traditional and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China wangtao6112@163.com 
Abstract
    [Objective] To investigate the effect of astragaloside Ⅳ/AST Ⅳ on drug-resistant strain of mouse lymphocytic leukemia based on p62-Nrf2 pathway.[Methods] The drug-resistant leukemia model was replicated in vitro, and drug-resistant cells were divided into 6 groups, namely blank group, model group, AST Ⅳ group, VER group, ML385 group, and ML385+AST Ⅳ group. They were subsequently treated with drugs for 48 hours. CCK-8 assay and ROS quantification were performed to observe the effects of AST Ⅳ on drug-resistance. To analyze the reversal mechanism of AST Ⅳ on drug resistance, Flow cytometry was performed to detect the changes of cell cycle and apoptosis rate, and real time RT-PCR and Western blot were performed to detect the expression of p62, Nrf2, HO-1, bcl-2, bax and Caspase-3 in p62-Nrf2 pathway.[Results] AST Ⅳ could down regulate the expression of p62, HO-1, bcl-2/bax, but up regulate the expression of Caspase-3, resulting in that drug-resistant cells were more sensitive to cisplatin because of the decreased ROS level. The proliferation of drug-resistant cells was inhibited. The cell cycle showed S-phase, G2, M phase arrest and the apoptosis rate increased.[Conclusion] AST Ⅳ can have the effect of reversing drug-resistance of leukemia cells, which may be related to the regulation of p62-Nrf2 pathway. However, the co-regulation of multiple pathways in cell fate still needs to be discussed.

You are the 2308226 visitor.

Copyright @ 2007
Address: 10 Boyanghu Road, West District of Tuanbo New City, Jinghai District, Tianjin 301617, China  Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.